We have collected information about Solid Lipid Nanoparticles Parenteral Drug Delivery for you. Follow the links to find out details on Solid Lipid Nanoparticles Parenteral Drug Delivery.
https://www.ncbi.nlm.nih.gov/pubmed/15109768
May 07, 2004 · 1. Adv Drug Deliv Rev. 2004 May 7;56(9):1257-72. Solid lipid nanoparticles for parenteral drug delivery. Wissing SA(1), Kayser O, Müller RH. Author information: (1)DDS, Drug Delivery Services, GmbH, Kronskamp 11, 24119 Kronshagen, Germany. This review describes the use of nanoparticles based on solid lipids for the parenteral application of drugs.Author: S.A. Wissing, Oliver Kayser, R.H. Muller
https://www.sciencedirect.com/science/article/pii/S0169409X04000456
This review describes the use of nanoparticles based on solid lipids for the parenteral application of drugs. Firstly, different types of nanoparticles based on solid lipids such as “solid lipid nanoparticles” (SLN), “nanostructured lipid carriers” (NLC) and “lipid drug conjugate” (LDC) nanoparticles are introduced and structural differences are pointed out.Author: S.A. Wissing, Oliver Kayser, R.H. Muller
https://www.researchgate.net/publication/8594937_Solid_lipid_nanoparticles_for_parenteral_drug_delivery
Solid lipid nanoparticles (SLNs) can be an attractive one option for oral drug delivery vehicles as they hold tremendous potential to improve the oral bioavailability of drugs, concomitant ...
https://www.sciencedirect.com/science/article/abs/pii/S0169409X04000456
This review describes the use of nanoparticles based on solid lipids for the parenteral application of drugs. Firstly, different types of nanoparticles based on solid lipids such as “solid lipid nanoparticles” (SLN), “nanostructured lipid carriers” (NLC) and “lipid drug conjugate” (LDC) nanoparticles are introduced and structural differences are pointed out.Author: S.A. Wissing, Oliver Kayser, R.H. Muller
https://www.ncbi.nlm.nih.gov/pubmed/30064267
INTRODUCTION: Solid lipid nanoparticles are promising drug carriers for systemic circulations as well as local applications. One of the major challenges for drug delivery is designing nanocarriers for efficient delivery of active substances to the target site and facilitating drug absorption.Author: Huiling Mu, René Holm
https://www.researchgate.net/publication/327107515_Solid_Lipid_Nanoparticles_A_potential_approach_in_drug_delivery_system
To improve the solubility and bioavailability of solid lipid nanoparticles (SLNs) are the new approach in drug delivery system. Since a decade, a lot of research works are performed to utilize ...
https://onlinelibrary.wiley.com/doi/pdf/10.1002/9781118444726.ch4
The chapter concludes with a summary of in vivo data on the improvement in oral bioavailability of poorly soluble drugs through the use of solid lipid nanoparticle dispersions and the application of such systems in parenteral drug delivery, with a special focus on pharmacokinetics and biodistribution.Author: Sonja Joseph, Heike Bunjes
http://www.icpjonline.com/documents/Vol1Issue11/08.pdf
Since a decade, trials are being made to utilize solid lipid nanoparticles (SLN) as alternative drug delivery system to colloidal drug delivery systems such as lipid emulsions, liposomes and polymeric nanopar-ticles. SLN combines the advantages of different colloidal carriers and also avoids some of …
https://www.intechopen.com/books/recent-advances-in-novel-drug-carrier-systems/lipid-nanoparticulate-drug-delivery-systems-a-revolution-in-dosage-form-design-and-development
3.14.2. Lipid nanoparticles for parenteral drug delivery. Lipid nanoparticles can be formulated for subcutaneous, intramuscular or intravenous administration. For intravenous administration, the small particle size is a prerequisite as passage through the needle and possibility of …Author: Anthony A. Attama, Mumuni A. Momoh, Philip F. Builders
Searching for Solid Lipid Nanoparticles Parenteral Drug Delivery?
You can just click the links above. The data is collected for you.
